Macular Research (MR) combines its strengths in basic and translational science with the centre’s clinical expertise in order to develop new treatments and cures for retinal disease.
One in three Canadians will experience age-related macular degeneration – the leading cause of vision loss in the elderly. Children can also suffer severe progressive vision loss due to inherited forms of macular degeneration and related retinal degenerative diseases.
As a result of research being done at the MR, new treatments are being developed to halt the progression of these blinding disorders. The MR is multidisciplinary in its focus on basic and clinical research in the visual sciences. Its mandate is to increase our knowledge of the visual system and its disorders, develop treatments for vision loss and provide broad training for trainees and residents in the visual sciences.
Led by Dr. Robert S. Molday, Director
- Located at the Eye Care Centre at Vancouver General Hospital with a secondary site at the UBC Life Science Centre
- MR has 16 principal investigators and 36 trainees
- Research at MR has led to far-reaching understanding of the genetic, molecular and cellular basis for age-related macular degeneration, retinitis pigmentosa, Stargardt disease, glaucoma, anaridia and related eye diseases. This knowledge, together with newly developed diagnostic imaging techniques, is being used to develop novel gene therapy, stem cell technology, and drug therapy strategies to treat these diseases.
Macular Degeneration & Vision
UBC Department of Ophthalmology & Visual Sciences
Eye Care Centre (VGH)
2550 Willow Street
Vancouver, B.C. V5Z 3N9
For more information visit: www.cmr.ubc.ca